Evidence map›Paper›PMID 29684006›Full record

ArticlePLoS neglected tropical diseases2018

Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.

Amena Aktar, M Arifur Rahman, Sadia Afrin, Aklima Akter, Taher Uddin, Tahirah Yasmin, Md Israk Nur Sami, Pinki Dash, Sultana Rownok Jahan, Fahima Chowdhury and 12 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Long-Term Kinetics of Serological Antibodies againstInternational journal of environmental research and public health · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Frontiers in medicine · 2023
    Review
  10. InactivatedJournal of microbiology and biotechnology · 2022
    Article
  11. Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Article
  12. Virus-like Particle Display ofACS infectious diseases · 2022
    Article
  13. Article
  14. A Global Perspective ofEnvironmental health insights · 2022
    Review
  15. Correlates of Protection for Cholera.The Journal of infectious diseases · 2021
    Article
  16. Article
  17. Systemic, Mucosal, and Memory Immune Responses following Cholera.Tropical medicine and infectious disease · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Amena AktarInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
M Arifur RahmanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Sadia AfrinInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Aklima AkterInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Taher UddinInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Tahirah YasminInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Md Israk Nur SamiInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Pinki DashInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Sultana Rownok JahanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Fahima ChowdhuryInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Ashraful I KhanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Regina C LaRocqueDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Richelle C CharlesDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Taufiqur Rahman BhuiyanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Anjali MandlikDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Meagan KellyDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Pavol KováčNIDDK, LBC, National Institutes of Health, Bethesda, Maryland, United States of America.
Peng XuNIDDK, LBC, National Institutes of Health, Bethesda, Maryland, United States of America.
Stephen B CalderwoodDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Jason B HarrisDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Firdausi QadriInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.ORCID 0000-0001-8459-304X
Edward T RyanDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
International Centre for Diarrhoeal Disease Research · BDHarvard University · USMassachusetts General Hospital · USNational Institutes of Health · USBoston Children's Hospital · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Reactions And Immunochemistry Of CarbohydratesZIADK059701 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOVAC, PAVOL · 2009 to 2019
$9.5M
Immune Responses to Vibrio cholerae infection and vaccination in HaitiR01AI099243 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B, IVERS, LOUISE C. · 2012 to 2022
$7.9M
Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
Training program in vaccine development and public healthD43TW005572 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI QADRI, FIRDAUSI, RYAN, EDWARD T. · 2000 to 2025
$5.4M
O-Specific Polysaccharide Responses and CholeraR37AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Edward T. Ryan · 2020 to 2026
$5.1M
Innate and early B cell responses to V. choleraeR01AI103055 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B · 2014 to 2018
$3.9M
O-Specific Polysaccharide Responses and CholeraR01AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2014 to 2018
$3.7M
High-throughput proteomic study of protective immunity in human cholera infectionK08AI089721 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHARLES, RICHELLE C · 2010 to 2014
$684k
Humoral and adaptive immune responses study in Vibrio cholerae infectionK43TW010362 · FIC · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI BHUIYAN, MD TAUFIQUR RAHMAN · 2016 to 2020
$359k
Mucosal immune response to oral cholera vaccine Peru 15R03AI063079 · NIAID · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI QADRI, FIRDAUSI · 2005 to 2007
$158k
FIC NIH HHS D43 TW005572FIC NIH HHS K43 TW010362NIAID NIH HHS K08 AI089721NIAID NIH HHS R01 AI099243NIAID NIH HHS R01 AI103055NIAID NIH HHS R01 AI106878NIAID NIH HHS R03 AI063079NIAID NIH HHS R37 AI106878NIAID NIH HHS U01 AI058935NIDDK NIH HHS P30 DK043351NIH HHS AI099243NIH HHS AI103055NIH HHS D43 TW005572NIH HHS K08 AI089721NIH HHS K43 TW010362NIH HHS R01 AI106878NIH HHS R03 AI063079NIH HHS U01 AI058935
6 · The paper itself

Abstract

backgroundThe mediators of protection against cholera, a severe dehydrating illness of humans caused by Vibrio cholerae, are unknown. We have previously shown that plasma IgA as well as memory B IgG cells targeting lipopolysaccharide (LPS) of Vibrio cholerae O1 correlate with protection against V. cholerae O1 infection among household contacts of cholera patients. Protection against cholera is serogroup specific, and serogroup specificity is defined by the O-specific polysaccharide (OSP) component of LPS. Therefore, we prospectively followed household contacts of cholera patients to determine whether OSP-specific immune responses present at the time of enrollment are associated with protection against V. cholerae infection. METHODOLOGY: In this study, we enrolled two hundred forty two household contacts of one hundred fifty index patients who were infected with Vibrio cholerae. We determined OSP-specific memory B cells and plasma IgA, IgG and IgM antibody responses on study entry (day 2). PRINCIPLE

findingsThe presence of OSP-specific plasma IgA, IgM, and IgG antibody responses on study entry were associated with a decrease in the risk of infection in household contacts (IgA, p = 0.015; IgM, p = 0.01, and IgG, p = 0.024). In addition, the presence of OSP-specific IgG memory B cell responses in peripheral blood on study entry was also associated with a decreased risk of infection (44% reduction; 95% CI: 31.1 to 99.8) in contacts. No protection was associated with cholera toxin B subunit (CtxB)-specific memory B cell responses.

conclusionThese results suggest that immune responses that target OSP, both in plasma and memory responses, may be important in mediating protection against infection with V. cholerae O1.

Indexed as

Immunologic MemoryAdolescentAdultAntibodies, BacterialBangladeshB-LymphocytesChildChild, PreschoolCholeraFamily CharacteristicsFemaleHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MMaleAntibodies, BacterialImmunoglobulin AImmunoglobulin GImmunoglobulin MO Antigens

Identifiers

PMID29684006
PMCPMC5912711
OpenAlexW2800601437

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.